BioCentriq

Newark, United States

BioCentriq is a cell and gene therapy development and manufacturing center.

$29.2M raised

Jan 2024

Series A

Top Investors

National Institute for Innovation in Manufacturing Biopharmaceuticals

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BioCentriq raised?

BioCentriq has raised $29.2M in total funding. The most recent round was Series A. The last funding was announced in January 2024.

Who are BioCentriq's investors?

BioCentriq's investors include National Institute for Innovation in Manufacturing Biopharmaceuticals.

Where is BioCentriq headquartered?

BioCentriq is headquartered in Newark, United States.

What does BioCentriq do?

BioCentriq is a cell and gene therapy development and manufacturing center.

What stage is BioCentriq at?

BioCentriq is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 3, 2024.

MLA

"BioCentriq — Funding & Investors." VCBacked, January 3, 2024, https://www.vcbacked.co/company/biocentriq. Accessed June 13, 2026.

APA

VCBacked. (2024). BioCentriq — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/biocentriq

Wikipedia (cite web)

{{cite web |title=BioCentriq — Funding & Investors |url=https://www.vcbacked.co/company/biocentriq |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 3, 2024.